Home / Ingredient Directory / Turkey Tail Mushroom

Reviewed by Yannis Lopez · Nutrition Industry Veteran

Last updated: August 6, 2026

Immunity & Wellness PSK/PSP Polysaccharides

Turkey Tail Mushroom

A rare medicinal mushroom with real clinical trial history -- as an adjunct, not a cure

Decades of clinical use in Japan

Multiple positive human RCTs

Important: These statements have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.

A note on the cancer research specifically: Turkey tail's PSK/PSP research is real, but it was studied and is used in Japan strictly as an adjunct to standard chemotherapy and surgery -- never as a standalone treatment or substitute for conventional oncology care. Anyone considering it during cancer treatment should discuss it directly with their oncologist first, since it can interact with treatment plans.

Overview

Turkey Tail (Trametes versicolor, also called Coriolus versicolor) is a common, fan-shaped bracket mushroom found growing on dead logs worldwide. Unlike most trending medicinal mushrooms, it isn't a newcomer to clinical research — its extracted polysaccharides, PSK (branded Krestin) and PSP, have been studied and used clinically in Japan for decades as an adjunct cancer therapy, alongside standard chemotherapy and surgery, under national health insurance coverage.

That's a meaningfully different evidence profile than most mushroom supplements get credit for. PSK is not FDA-approved and is sold in the U.S. only as a dietary supplement — but the underlying research includes real randomized controlled trials with hard survival numbers, not just preclinical or observational data.

Potential Benefits

Adjunct Cancer Survival Support

A randomized controlled trial in colorectal cancer patients found 5-year disease-free survival of 73.0% with PSK added to standard adjuvant chemotherapy, versus 58.8% for chemotherapy alone -- a statistically significant difference.

Immune & Hematological Support

A systematic review of PSK in lung cancer found consistent improvements in immune and hematological function -- including increased white blood cells, hemoglobin, and NK cell activity -- alongside shortened chemotherapy-induced bone marrow suppression.

Immune Cell Modulation

Mechanistic research shows PSK helps correct immune imbalances caused by surgery and chemotherapy, supporting dendritic cell maturation and promoting a healthier balance of immune signaling molecules.

Gut & Prebiotic Effects

Turkey tail polysaccharides also show prebiotic activity in preliminary research, supporting beneficial gut bacteria populations -- a secondary interest area distinct from its main cancer-adjunct research.

Typical Dosage

Standard Daily Dose

1,000–3,000mg

Standardized PSK or PSP extract, divided across 2-3 doses; clinical trials used up to 3g/day

What to Look For on the Label

Standardized PSK or PSP extract

Not just "mushroom powder" -- look for a stated polysaccharide-K or polysaccharopeptide percentage

Pro Tips

If using during active cancer treatment, this is a conversation for your oncologist, not a self-directed decision
Hot-water extraction is standard for PSK/PSP -- alcohol-only extracts may not contain the studied compounds in meaningful amounts
Look for third-party testing given significant quality variation across turkey tail products
Most positive trials ran for months alongside chemotherapy cycles, not as a short-term general immune boost

Research Snapshot

A randomized controlled trial in 207 patients with stage II or III colorectal cancer found that adding PSK to standard oral adjuvant chemotherapy significantly improved 5-year disease-free survival (73.0% vs. 58.8%, p=0.016) compared to chemotherapy alone. A separate systematic review of PSK trials in lung cancer found consistent improvements in immune function, reduced tumor-associated symptoms, and extended survival across most included randomized controlled trials, though the review noted many trials predate modern methodology standards.

Source: Ohwada et al., British Journal of Cancer (2004)

How Turkey Tail Compares

Ingredient	Best For	Key Difference
Turkey Tail	Adjunct Cancer Support, Immunity	Only medicinal mushroom with decades of adjunct oncology RCT data
Reishi Mushroom	General Immunity, Stress	Broader wellness focus; less cancer-specific clinical history
Lion's Mane	Cognitive Function, Nerve Growth	Targets brain health, not immune/cancer pathways
Cordyceps	Energy, Exercise Performance	Athletic-performance focus, different mechanism entirely

These are the most common comparisons our customers ask about in-store.

Popular Stacks with Turkey Tail

Immune Foundation

Turkey Tail + Reishi + Vitamin D3

Broad-spectrum immune support

Gut & Immune

Turkey Tail + Probiotics + Colostrum

Combines prebiotic and immune pathways

Full Mushroom Complex

Turkey Tail + Lion's Mane + Cordyceps

Covers immunity, cognition, and energy

Frequently Asked Questions

Can turkey tail mushroom cure cancer?

No, and no reputable source claims that. Its extracted compound PSK (Krestin) is approved in Japan as an adjunct to standard chemotherapy and surgery, not a replacement for them -- meaning it's used alongside conventional treatment, under medical supervision, based on trials showing improved survival and immune markers when added to standard care.

Is turkey tail mushroom approved by the FDA for cancer treatment?

No. PSK/PSP extracts are approved as adjunct cancer therapy in Japan, but not by the FDA or EMA. In the United States, turkey tail products are sold only as dietary supplements, without cancer-treatment claims, and cannot legally be marketed to diagnose, treat, cure, or prevent any disease.

What's the difference between turkey tail supplements and the PSK used in Japanese trials?

Most positive clinical trials used a specific, standardized, pharmaceutical-grade extract (PSK/Krestin or PSP) manufactured to consistent potency. Over-the-counter turkey tail supplements vary widely in extraction method and standardization, and most haven't been tested in the same rigorous trials -- an important gap between the research and what's on a store shelf.

Sources & References

1. Ohwada, S., et al. (2004). Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. British Journal of Cancer, 90(5), 1003–1010.

2. Fritz, H., Kennedy, D.A., Ishii, M., et al. (2015). Polysaccharide K and Coriolus versicolor Extracts for Lung Cancer: A Systematic Review. Integrative Cancer Therapies, 14(3), 201–211.

3. Maehara, Y., Tsujitani, S., Saeki, H., et al. (2012). Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN): review of development and future perspectives. Surgery Today, 42(1), 8–28.

All references are peer-reviewed studies or position stands from reputable organizations.